BioNTech SE (BNTX) Short-term Investments (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Short-term Investments data on file, last reported at $8.4 billion in Q4 2025.

• For the quarter ending Q4 2025, Short-term Investments rose 11.73% year-over-year to $8.4 billion; the trailing twelve-month figure through Dec 2025 stood at $8.4 billion (up 11.73% YoY), and the FY2025 full-year result was $8.1 billion, up 8.44% from the prior year.
• Short-term Investments climbed to $8.4 billion in Q4 2025, from $5.2 billion in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $8.4 billion in Q4 2025 to a low of $603118.1 in Q1 2021.
• A 5-year average of $3.5 billion and a median of $3.3 billion in 2023 frame the typical range for Short-term Investments.
• Peak annual rise in Short-term Investments reached 8906.72% in 2022, while the deepest fall reached 55.73% in 2022.
• Tracing BNTX's Short-term Investments over 5 years: stood at $436.5 million in 2021, then tumbled by 55.73% to $193.2 million in 2022, then jumped by 2620.16% to $5.3 billion in 2023, then surged by 42.75% to $7.5 billion in 2024, then grew by 11.73% to $8.4 billion in 2025.
• Business Quant data shows BNTX's Short-term Investments at $8.4 billion in Q4 2025, $5.2 billion in Q3 2025, and $4.3 billion in Q2 2025.